Fate Therapeutics to Present at the 5th Annual Cell & Gene Therapy Investor Day – GlobeNewswire (press release)
|
Fate Therapeutics to Present at the 5th Annual Cell & Gene Therapy Investor Day
GlobeNewswire (press release) SAN DIEGO, April 20, 2017 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today … |
